Fumaric Acid

Fumaric Acid

SCHEMBL7775335

NC(CN1CCN(c2ncccn2)CC1)c1nc2ccccc2s1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 known ✓ P14416 5/20 0.52
HTR2A known ✓ P28223 3/20 0.52
SLC6A2 known ✓ P23975 1/20 0.48
HRH1 known ✓ P35367 1/20 0.48
HTR2B known ✓ P41595 1/20 0.48
MEN1 known ✓ O00255 1/20 0.41
KMT2A known ✓ Q03164 1/20 0.41
HTR1A P08908 6/20 0.52
HTR7 P34969 4/20 0.52
DRD4 P21917 3/20 0.48
DRD3 P35462 3/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2C P18825 1/20 0.48
ADRA1A P35348 1/20 0.48
SIGMAR1 Q99720 1/20 0.48
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
LMNA P02545 1/20 0.43
PMP22 Q01453 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7773411 0.91 DRD2 (0.57) HTR1ADRD2HTR7HTR2ADRD4
Fumaric Acid SCHEMBL7776844 0.91 HTR1A (0.42) HTR1ADRD2HTR7HTR2ADRD4
Fumaric Acid SCHEMBL7776885 0.91 DRD2 (0.42) HTR1ADRD2HTR7HTR2ADRD4
Fumaric Acid SCHEMBL7775337 0.90 ALDH1A1 (0.52) HTR1ADRD2HTR7HTR2ADRD4
Fumaric Acid SCHEMBL7773436 0.89 DRD2 (0.51) HTR1ADRD2HTR7HTR2ADRD4
Fumaric Acid SCHEMBL7775435 0.89 DRD2 (0.58) HTR1ADRD2HTR7HTR2ADRD4
Fumaric Acid SCHEMBL7775352 0.88 KDM4E (0.42) HTR1ADRD2HTR7HTR2ADRD4
Fumaric Acid SCHEMBL7773336 0.82 HTR1A (0.48) HTR1ADRD2HTR7HTR2ADRD3
SCHEMBL7773395 0.81 SIGMAR1 (0.46) HTR1ADRD2HTR7HTR2ADRD4
SCHEMBL7773492 0.81 DRD2 (0.45) HTR1ADRD2HTR7HTR2ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed